![Pat O’Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Pat O’Sullivan worked at Genzyme Therapeutics Ltd. from 2001 to 2022 as Vice President-Global Supply Chain.
From 2022 to 2026, Mr. O’Sullivan worked at Amicus Therapeutics, Inc. as Chief Technical Operations Officer.
Mr. O’Sullivan completed an MBA at The Open University and an undergraduate degree at Munster Technological University.
Anciens postes connus de Pat O’Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Directeur des opérations | 27/04/2026 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01/08/2022 |
Formation de Pat O’Sullivan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Munster Technological University
 Munster Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
